Your browser doesn't support javascript.
loading
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.
Xu, Xiaowei; De Angelis, Carmine; Burke, Kathleen A; Nardone, Agostina; Hu, Huizhong; Qin, Lanfang; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; Heiser, Laura M; Wang, Nicholas; Ng, Charlotte K Y; Chen, Edward S; Renwick, Alexander; Wang, Tao; Nanda, Sarmistha; Shea, Martin; Mitchell, Tamika; Rajendran, Mahitha; Waters, Ian; Zabransky, Daniel J; Scott, Kenneth L; Gutierrez, Carolina; Nagi, Chandandeep; Geyer, Felipe C; Chamness, Gary C; Park, Ben H; Shaw, Chad A; Hilsenbeck, Susan G; Rimawi, Mothaffar F; Gray, Joe W; Weigelt, Britta; Reis-Filho, Jorge S; Osborne, C Kent; Schiff, Rachel.
Afiliação
  • Xu X; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • De Angelis C; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Burke KA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas.
  • Nardone A; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Hu H; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Qin L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Veeraraghavan J; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Sethunath V; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Heiser LM; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Wang N; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Ng CKY; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Chen ES; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Renwick A; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Wang T; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Nanda S; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Shea M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Mitchell T; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas.
  • Rajendran M; Department of Biomedical Engineering and Oregon Center for Spatial Systems Biomedicine, Oregon Health & Science University, Portland, Oregon.
  • Waters I; Department of Biomedical Engineering and Oregon Center for Spatial Systems Biomedicine, Oregon Health & Science University, Portland, Oregon.
  • Zabransky DJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Scott KL; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Gutierrez C; Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Nagi C; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Geyer FC; Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Chamness GC; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Park BH; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Shaw CA; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Hilsenbeck SG; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Rimawi MF; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Gray JW; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Weigelt B; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Reis-Filho JS; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Osborne CK; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Schiff R; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
Clin Cancer Res ; 23(17): 5123-5134, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28487443
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Terapia de Alvo Molecular Limite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Terapia de Alvo Molecular Limite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article